These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29869454)

  • 1. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
    Koo KC; Dasgupta P
    Yonsei Med J; 2018 Jul; 59(5):567-579. PubMed ID: 29869454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
    Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
    Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
    Kim J; Park JS; Ham WS
    Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature.
    Ost P; Bossi A; Decaestecker K; De Meerleer G; Giannarini G; Karnes RJ; Roach M; Briganti A
    Eur Urol; 2015 May; 67(5):852-63. PubMed ID: 25240974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.
    Tosoian JJ; Gorin MA; Ross AE; Pienta KJ; Tran PT; Schaeffer EM
    Nat Rev Urol; 2017 Jan; 14(1):15-25. PubMed ID: 27725639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
    Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
    World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligometastatic Prostate Cancer.
    Navrátil J; Poprach A; Lakomý R; Kocák I; Vašina J; Krupa P; Vyzula R
    Klin Onkol; 2019; 32(2):97-100. PubMed ID: 30995848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
    Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
    Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
    Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review.
    Miura N; Pradere B; Mori K; Mostafaei H; Quhal F; Misrai V; D'Andrea D; Albisinni S; Papalia R; Saika T; Scarpa RM; Shariat SF; Esperto F
    Minerva Urol Nefrol; 2020 Oct; 72(5):531-542. PubMed ID: 32550632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
    Larbi A; Dallaudière B; Pasoglou V; Padhani A; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
    Prostate; 2016 Aug; 76(11):1024-33. PubMed ID: 27197649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer.
    De Bleser E; Tran PT; Ost P
    Curr Opin Urol; 2017 Nov; 27(6):587-595. PubMed ID: 28816714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.
    Hijazi S; Meller B; Leitsmann C; Strauss A; Meller J; Ritter CO; Lotz J; Schildhaus HU; Trojan L; Sahlmann CO
    Prostate; 2015 Dec; 75(16):1934-40. PubMed ID: 26356236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
    Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
    Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
    Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary.
    Matulay JT; DeCastro GJ
    Curr Urol Rep; 2017 Jul; 18(7):53. PubMed ID: 28589400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?].
    Kretschmer A; Herlemann A; Stief CG; Gratzke C
    Urologe A; 2017 May; 56(5):599-603. PubMed ID: 28314971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.